Young RC - Search Results

1

Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.

Lai GM, Ozols RF, Young RC, Hamilton TC. Lai GM, et al. Among authors: young rc. J Natl Cancer Inst. 1989 Apr 5;81(7):535-9. doi: 10.1093/jnci/81.7.535. J Natl Cancer Inst. 1989. PMID: 2493524

2

Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.

Louie KG, Hamilton TC, Shoemaker RH, Young RC, Ozols RF. Louie KG, et al. Among authors: young rc. Invest New Drugs. 1992 Jul;10(2):73-8. doi: 10.1007/BF00873120. Invest New Drugs. 1992. PMID: 1500268

3

Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results.

O'Dwyer PJ, Hamilton TC, Young RC, LaCreta FP, Carp N, Tew KD, Padavic K, Comis RL, Ozols RF. O'Dwyer PJ, et al. Among authors: young rc. J Natl Cancer Inst. 1992 Feb 19;84(4):264-7. doi: 10.1093/jnci/84.4.264. J Natl Cancer Inst. 1992. PMID: 1734088 No abstract available.

4

Evaluation of platinum-DNA adduct levels relative to known prognostic variables in a cohort of ovarian cancer patients.

Reed E, Ostchega Y, Steinberg SM, Yuspa SH, Young RC, Ozols RF, Poirier MC. Reed E, et al. Among authors: young rc. Cancer Res. 1990 Apr 15;50(8):2256-60. Cancer Res. 1990. PMID: 2180564

5

High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer.

Rothenberg ML, Ostchega Y, Steinberg SM, Young RC, Hummel S, Ozols RF. Rothenberg ML, et al. Among authors: young rc. J Natl Cancer Inst. 1988 Nov 16;80(18):1488-92. doi: 10.1093/jnci/80.18.1488. J Natl Cancer Inst. 1988. PMID: 2846858

6

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer.

Lai GM, Ozols RF, Smyth JF, Young RC, Hamilton TC. Lai GM, et al. Among authors: young rc. Biochem Pharmacol. 1988 Dec 15;37(24):4597-600. doi: 10.1016/0006-2952(88)90325-5. Biochem Pharmacol. 1988. PMID: 3144285 No abstract available.

7

Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer.

Ozols RF, Hamilton TC, Young RC. Ozols RF, et al. Among authors: young rc. Prog Clin Biol Res. 1988;276:287-93. Prog Clin Biol Res. 1988. PMID: 3174681 No abstract available.

8

Multidrug resistance in ovarian cancer.

Fojo A, Hamilton TC, Young RC, Ozols RF. Fojo A, et al. Among authors: young rc. Cancer. 1987 Oct 15;60(8 Suppl):2075-80. doi: 10.1002/1097-0142(19901015)60:8+<2075::aid-cncr2820601521>3.0.co;2-f. Cancer. 1987. PMID: 3308067 Review.

9

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF. Behrens BC, et al. Among authors: young rc. Cancer Res. 1987 Jan 15;47(2):414-8. Cancer Res. 1987. PMID: 3539322

10

Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

Green JA, Vistica DT, Young RC, Hamilton TC, Rogan AM, Ozols RF. Green JA, et al. Among authors: young rc. Cancer Res. 1984 Nov;44(11):5427-31. Cancer Res. 1984. PMID: 6488194

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

708 results

Search Page

Filters